These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1924251)

  • 41. Molecular and physiological differentiation between pathogenic and nonpathogenic Acanthamoeba.
    Khan NA; Jarroll EL; Paget TA
    Curr Microbiol; 2002 Sep; 45(3):197-202. PubMed ID: 12177742
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acanthamoeba genotypes T3 and T4 as causative agents of amoebic keratitis in Mexico.
    Omaña-Molina M; Vanzzini-Zago V; Hernandez-Martinez D; Gonzalez-Robles A; Salazar-Villatoro L; Ramirez-Flores E; Oregon-Miranda E; Lorenzo-Morales J; Martinez-Palomo A
    Parasitol Res; 2016 Feb; 115(2):873-8. PubMed ID: 26581373
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Physiological, morphological, and immunochemical parameters used for the characterization of clinical and environmental isolates of Acanthamoeba.
    Becker-Finco A; Costa AO; Silva SK; Ramada JS; Furst C; Stinghen AE; De Figueiredo BC; De Moura J; Alvarenga LM
    Parasitology; 2013 Mar; 140(3):396-405. PubMed ID: 23137846
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Filter-culture technique using amoeba saline transport medium for the noninvasive diagnosis of Acanthamoeba keratitis.
    Gradus MS; Koenig SB; Hyndiuk RA; DeCarlo J
    Am J Clin Pathol; 1989 Nov; 92(5):682-5. PubMed ID: 2816824
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antimicrobial action of biguanides on the viability of Acanthamoeba cysts and assessment of cell toxicity.
    Mafra CS; Carrijo-Carvalho LC; Chudzinski-Tavassi AM; Taguchi FM; Foronda AS; Carvalho FR; de Freitas D
    Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6363-72. PubMed ID: 23900604
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Susceptibility of corneas from various animal species to in vitro binding and invasion by Acanthamoeba castellanii [corrected].
    Niederkorn JY; Ubelaker JE; McCulley JP; Stewart GL; Meyer DR; Mellon JA; Silvany RE; He YG; Pidherney M; Martin JH
    Invest Ophthalmol Vis Sci; 1992 Jan; 33(1):104-12. PubMed ID: 1730531
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Corneal virulence, cytopathic effect on human keratocytes and genetic characterization of Acanthamoeba.
    Badenoch PR; Adams M; Coster DJ
    Int J Parasitol; 1995 Feb; 25(2):229-39. PubMed ID: 7622330
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Close relatedness of Acanthamoeba pustulosa with Acanthamoeba palestinensis based on isoenzyme profiles and rDNA PCR-RFLP patterns.
    Kim YH; Ock MS; Yun HC; Hwang MY; Yu HS; Kong HH; Chung DI
    Korean J Parasitol; 1996 Dec; 34(4):259-66. PubMed ID: 9017912
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Purification and characterization of an extracellular serine proteinase from Acanthamoeba castellanii.
    Cho JH; Na BK; Kim TS; Song CY
    IUBMB Life; 2000 Sep; 50(3):209-14. PubMed ID: 11142349
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vivo tandem scanning confocal microscopy in acanthamoeba keratitis.
    Cho BJ; Holland EJ
    Korean J Ophthalmol; 1998 Dec; 12(2):112-7. PubMed ID: 10188372
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acanthamoeba corneal infection in a contact lens wearer.
    Logar J; Kraut A
    J Infect; 1997 Nov; 35(3):237-40. PubMed ID: 9459394
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The diagnosis of Acanthamoeba keratitis. The identification of the first case in Russia].
    Volkov VV; Gordeeva LM; Kaminskaia LIu; Zabaĭkina TP; Astakhov SIu
    Med Parazitol (Mosk); 1993; (5):60-3. PubMed ID: 8127276
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical and histologic evaluations of experimental Acanthamoeba keratitis.
    Polat ZA; Ozcelik S; Vural A; Yildiz E; Cetin A
    Parasitol Res; 2007 Nov; 101(6):1621-5. PubMed ID: 17701053
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epidemiological typing of Acanthamoeba strains isolated from keratitis cases in Belgium.
    De Jonckheere JF
    Bull Soc Belge Ophtalmol; 2003; (287):27-33. PubMed ID: 12784575
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Box Behnken design of siRNA-loaded liposomes for the treatment of a murine model of ocular keratitis caused by Acanthamoeba.
    Zorzi GK; Schuh RS; Maschio VJ; Brazil NT; Rott MB; Teixeira HF
    Colloids Surf B Biointerfaces; 2019 Jan; 173():725-732. PubMed ID: 30384269
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of the innate and adaptive immune responses in Acanthamoeba keratitis.
    Niederkorn JY
    Arch Immunol Ther Exp (Warsz); 2002; 50(1):53-9. PubMed ID: 11916309
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genotyping of Acanthamoeba isolates from clinical and environmental specimens in Iran.
    Niyyati M; Lorenzo-Morales J; Rezaie S; Rahimi F; Mohebali M; Maghsood AH; Motevalli-Haghi A; Martín-Navarro CM; Farnia S; Valladares B; Rezaeian M
    Exp Parasitol; 2009 Mar; 121(3):242-5. PubMed ID: 19059239
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Occurrence of Acanthamoeba genotypes in Central West Malaysian environments.
    Basher MHA; Ithoi I; Mahmud R; Abdulsalam AM; Foead AI; Dawaki S; Atroosh WMM; Nissapatorn V; Abdullah WO
    Acta Trop; 2018 Feb; 178():219-228. PubMed ID: 29203378
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Corneal "Plaque" formation after anti-acanthamoeba therapy in acanthamoeba keratitis.
    Mittal R; Ahooja H; Sapra N
    Indian J Ophthalmol; 2018 Nov; 66(11):1623-1624. PubMed ID: 30355882
    [No Abstract]   [Full Text] [Related]  

  • 60. Acanthamoeba keratitis.
    Graffi S; Peretz A; Jabaly H; Naftali M
    Isr Med Assoc J; 2013 Apr; 15(4):182-5. PubMed ID: 23781754
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.